In response to NIDA's request for applications to support 'Research Education Grants in Drug Abuse and Addiction,' this application seeks funding to continue, improve, and expand the accomplishments of the Clinical Addiction Research and Education (CARE) Program at the Albert Einstein College of Medicine (Einstein) and its University Hospital, Montefiore Medical Center, including an enhanced focus on HIV and substance abuse. The centerpiece of the CARE Program, which began in 2002, is a post-doctoral fellowship program for physicians interested in careers in drug abuse research and clinical practice. The CARE Program is based in Einstein's Department of Medicine, and draws additional NIDA-funded research mentors from Einstein's Departments of Epidemiology & Population Health and Psychiatry & Behavioral Sciences, as well as from other New York City institutions. In addition to providing clinical research training necessary to prepare physicians for independent careers as HIV and substance abuse researchers, CARE Program faculty collaborate with key educational leaders at Montefiore Medical Center to enhance evidence-based substance abuse training for residents in Internal and Family Medicine, and for Einstein medical students. The CARE Program has been highly successful in its first eight years of operation, and this competitive renewal will build on that success and create new opportunities for research education and training in HIV and substance abuse. The current specific aims are: 1. to continue, improve, and expand the accomplishments of the CARE Fellowship Program, an innovative research-intensive fellowship program for physicians who have completed residencies in Internal Medicine, Family Medicine, or Psychiatry and are seeking careers that combine HIV and substance abuse research and clinical work. 2. To continue, improve, and expand the scope of the CARE Educational Program, an enhanced substance abuse research and clinical training program for residents at Montefiore Medical Center and students at Albert Einstein College of Medicine.

Public Health Relevance

There is a shortage of well-qualified researchers prepared to conduct clinical; translational; prevention; health services; and treatment research with drug users. At Albert Einstein College of Medicine and its University Hospital; Montefiore Medical Center; we are uniquely positioned to provide such training; given our strong addiction treatment programs; our cadre of outstanding NIDA-funded researchers; and our ability to provide formal training in both clinical research methods and addiction medicine. We are also located in a community with a high prevalence of both HIV and substance abuse related disorders; primarily among racial and ethnic minorities. This application seeks funding to continue a post-doctoral fellowship program for physicians interested in careers in HIV and substance abuse research and clinical practice. We also propose to continue an HIV and substance abuse research and clinical training program for residents and students.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Education Projects (R25)
Project #
6R25DA023021-09
Application #
9195776
Study Section
Special Emphasis Panel (ZDA1-GXM-A (01))
Program Officer
Aklin, Will
Project Start
2007-05-01
Project End
2016-04-30
Budget Start
2015-09-01
Budget End
2016-04-30
Support Year
9
Fiscal Year
2014
Total Cost
$235,949
Indirect Cost
$15,996
Name
Albert Einstein College of Medicine, Inc
Department
Type
DUNS #
079783367
City
Bronx
State
NY
Country
United States
Zip Code
10461
Adams, Tangeria R; Arnsten, Julia H; Ning, Yuming et al. (2018) Feasibility and Preliminary Effectiveness of Varenicline for Treating Co-Occurring Cannabis and Tobacco Use. J Psychoactive Drugs 50:12-18
Patel, Viraj V; Ginsburg, Zoƫ; Golub, Sarit A et al. (2018) Empowering With PrEP (E-PrEP), a Peer-Led Social Media-Based Intervention to Facilitate HIV Preexposure Prophylaxis Adoption Among Young Black and Latinx Gay and Bisexual Men: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc 7:e11375
Batchelder, A W; Cockerham-Colas, L; Peyser, D et al. (2017) Perceived benefits of the hepatitis C peer educators: a qualitative investigation. Harm Reduct J 14:67
Ross, Jonathan; Hanna, David B; Felsen, Uriel R et al. (2017) Emerging from the database shadows: characterizing undocumented immigrants in a large cohort of HIV-infected persons. AIDS Care 29:1491-1498
Heo, Moonseong; Litwin, Alain H; Blackstock, Oni et al. (2017) Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms. Stat Methods Med Res 26:399-413
Shah, Pooja A; Cunningham, Chinazo O; Brisbane, Mia T et al. (2017) Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment. J Addict Med 11:494-497
Felsen, Uriel R; Cunningham, Chinazo O; Heo, Moonseong et al. (2017) Expanded HIV Testing Strategy Leveraging the Electronic Medical Record Uncovers Undiagnosed Infection Among Hospitalized Patients. J Acquir Immune Defic Syndr 75:27-34
Gupta, Sanchit; Lounsbury, David W; Patel, Viraj V (2017) Low Awareness and Use of Preexposure Prophylaxis in a Diverse Online Sample of Men Who Have Sex With Men in New York City. J Assoc Nurses AIDS Care 28:27-33
Doorley, Sara L; Ho, Cheryl J; Echeverria, Elizabeth et al. (2017) Buprenorphine shared medical appointments for the treatment of opioid dependence in a homeless clinic. Subst Abus 38:26-30
Fox, Aaron D; Sohler, Nancy L; Frost, Taeko et al. (2017) Development and evaluation of a community-based buprenorphine treatment intervention. Harm Reduct J 14:23

Showing the most recent 10 out of 94 publications